I’d squirt the spray into my nose, where it’d drip to the back of my throat. The taste was potent: The office kept a dish of ...

A 60-year-old anesthetic is rewiring traumatized brains in hours, not months. Could this change everything for millions ...

Elkedonia will develop first-in-class Elk1 inhibitors for treatment-resistant depression, targeting neuroplasticity without ...

Serenity Mental Health Center in Sandy Springs is offering patients transcranial magnetic stimulation, a non-invasive ...

Angelini Ventures has joined a syndicate of European life sciences investors to back Elkedonia, a French biotech developing a ...

The state’s governor signed legislation to allow clinical trials of a psychedelic drug that shows promise for veterans in ...

The future holds promise for robots to actively collaborate in diverse aspects of human endeavor, transforming industries ...

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", "NRx" or the "Company"), a clinical-stage biopharmaceutical ...

An estimated 7,000 people from all 50 U.S. states and 39 countries are expected to attend Psychedelic Science 2025. Boulder ...

One in five Americans report anxiety or depression ... reset of the brain with structured therapy to create lasting transformation. As ketamine therapy becomes more mainstream, not all providers ...

NRx Pharmaceuticals (NASDAQ: NRXP) and its wholly owned subsidiary HOPE Therapeutics, Inc. announced participation in the H.C. Wainwright 6th Annual ...

President Donald Trump said he did not know anything about Tesla CEO Elon Musk 's alleged use of drugs while at the White House, while responding to a journalist's question about a New York Times ...